4
Changes in Ownership
IONIS PHARMACEUTICALS INC Filed Acc 0000874015-24-000073
EVP, Chief Scientific Officer sold 6,745 shares at $50.42 ($340,063)
- EVP, Chief Scientific Officer acquired 18,314 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
BENNETT C FRANK · EVP, Chief Scientific Officer
Table I: Non-derivative
2 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2024-01-16 | Exercise or conversion : show line 1 in the form | +18,314 | 84,068 | D | ||
| 2024-01-17 | Sale : show line 2 in the form | −6,745 | $50.42 | $340,063 | 77,323 | D |
| Open-market sales · 6,745 sh · avg $50.42 · $340,063 | ||||||
Table II: Derivative
1 line| Date | Transaction | Shares | Exercise | Underlying | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2024-01-16 | Exercise or conversion : show line 3 in the form Restricted Stock Unit | −18,314 | $0.00 | 18,314 | 23,500 | D |
Loading xslF345X05/edgardoc.xml…